缩写名/全名 |
MINI-REV MED CHEM
MINI-REVIEWS IN MEDICINAL CHEMISTRY |
||||||||||||||||||||
ISSN号 | 1389-5575 | ||||||||||||||||||||
研究方向 | 医学-医药化学 | ||||||||||||||||||||
影响因子 | 2015:2.841, 2016:2.661, 2017:2.645, 2018:2.842, 2019:2.733, | ||||||||||||||||||||
出版国家 | NETHERLANDS | ||||||||||||||||||||
出版周期 | Quarterly | ||||||||||||||||||||
年文章数 | 118 | ||||||||||||||||||||
出版年份 | 2001 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 平均6.0个月 |
||||||||||||||||||||
录用比例 | 约75% | ||||||||||||||||||||
投稿链接 | http://bsp-cms.eurekaselect.com/index.php/MRMC | ||||||||||||||||||||
投稿官网 | http://benthamscience.com/journal/index.php?journalID=mrmc | ||||||||||||||||||||
h-index | 79 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1389-5575%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Recent Development of Oridonin Derivatives with Diverse Pharmacological Activities. Author: Cheng W1, Huang C2, Ma W3, Tian X1, Zhang X1. Journal: Mini Rev Med Chem. 2019;19(2):114-124. doi: 10.2174/1389557517666170417170609. PubMed DOI |
2. | Medicinal Purposes: Bioactive Metabolites from Marine-derived Organisms. Author: Li T1, Ding T2,3, Li J2,3. Journal: Mini Rev Med Chem. 2019;19(2):138-164. doi: 10.2174/1389557517666170927113143. PubMed DOI |
3. | Marine Natural Product Bis-indole Alkaloid Caulerpin: Chemistry and Biology. Author: Lunagariya J1, Bhadja P2, Zhong S1, Vekariya R3, Xu S1. Journal: Mini Rev Med Chem. 2019;19(9):751-761. doi: 10.2174/1389557517666170927154231. PubMed DOI |
4. | Ryanodine Receptors for Drugs and Insecticides: An Overview. Author: Sun Z1, Xu H1. Journal: Mini Rev Med Chem. 2019;19(1):22-33. doi: 10.2174/1389557518666180330112908. PubMed DOI |
5. | The Relationship between Pharmacological Properties and Structure- Activity of Chrysin Derivatives. Author: Li Y1, Li YP1, He J2, Liu D1, Zhang QZ1, Li K1, Zheng X1, Tang GT1, Guo Y1, Liu Y1. Journal: Mini Rev Med Chem. 2019;19(7):555-568. doi: 10.2174/1389557518666180424094821. PubMed DOI |
6. | PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDLCholesterol. Author: Wang Y1, Liu ZP1. Journal: Mini Rev Med Chem. 2019;19(2):165-176. doi: 10.2174/1389557518666180423111442. PubMed DOI |
7. | Pharmacological Effects and Chemical Constituents of Bupleurum. Author: Sun P1,2, Li Y1, Wei S1, Zhao T1, Wang Y3, Song C1, Xue L1,2, Wang F4, Xiao L5, Wu J1, Qiao M1. Journal: Mini Rev Med Chem. 2019;19(1):34-55. doi: 10.2174/1871520618666180628155931. PubMed DOI |
8. | Novel Resveratrol-chalcone Derivatives: Synthesis and Biological Evaluation. Author: Ma Y1, Zheng X2, Zhu P3, Liu B3, Gao H3, Mao Z3, Zhang L3, Wan C2. Journal: Mini Rev Med Chem. 2019;19(5):424-436. doi: 10.2174/1389557518666180727165358. PubMed DOI |
9. | Beauvericin, A Fusarium Mycotoxin: Anticancer Activity, Mechanisms, and Human Exposure Risk Assessment. Author: Wu Q1, Patocka J2,3, Kuca K4. Journal: Mini Rev Med Chem. 2019;19(3):206-214. doi: 10.2174/1389557518666180928161808. PubMed DOI |
10. | Recent Progress of Supercritical Carbon Dioxide in Producing Natural Nanomaterials. Author: Xie M1, Xu M1, Chen X1, Li Y2. Journal: Mini Rev Med Chem. 2019;19(6):465-476. doi: 10.2174/1389557518666181015152952. PubMed DOI |
|
|